You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MRNA Sale Disclosure
Hoge Stephen · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$2.74M
Hoge Stephen President
MRNA
Moderna
MRNA
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
MRNA daily price context
Close on/before transaction
$52.13
Jun 15, 2026
First close after public filing
$63.96
Jun 18, 2026
30-day return after filing
-3.35%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 53,336 shares @ $51.37
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001682852-26-000121
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$3.76M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA | Exercise | Jun 15, 2026 | $712.88K |
| Moderna, Inc. MRNA Current | Sale | Jun 15, 2026 | $2.74M |
| Moderna, Inc. MRNA | Exercise | Jun 15, 2026 | $0 |
| Moderna, Inc. MRNA | Exercise | Jun 15, 2026 | $0 |
| Moderna, Inc. MRNA | Exercise | Jun 15, 2026 | $308.51K |